10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001683168-23-007820`
Period End Date	20230930
Filing Date	20231109
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	xenetic_i10q-093023_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 48 Income Statement 56 Cash Flow Statement 38 Stockholders Equity 23

Balance Sheet 48 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$9.78M	USD	Point-in-time
Cash	`Cash`	$13.10M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.48M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$556.09K	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.65M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.26M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.07M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$704.43K	USD	Point-in-time
Total assets	`Assets`	$14.72M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	1.52M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	1.54M	shares	Point-in-time
Total assets	`Assets`	$11.96M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	1.52M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	1.53M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$287.36K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$448.56K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$619.94K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$785.80K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.07M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.07M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 10,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 1,535,301 and 1,519,360 shares issued as of September 30, 2023 and December 31, 2022, respectively; 1,532,600 and 1,516,659 shares outstanding as of September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$1.54K	USD	Point-in-time
Common stock, $0.001 par value; 10,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 1,535,301 and 1,519,360 shares issued as of September 30, 2023 and December 31, 2022, respectively; 1,532,600 and 1,516,659 shares outstanding as of September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$1.52K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$207.98M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$207.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-192.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-189.10M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockCommonValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockCommonValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$18.39M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.19M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.88M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.52M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.89M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.72M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.96M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-1.94	USD	3 Qtrs
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-0.56	USD	1 Quarter
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-3.64	USD	3 Qtrs
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-0.69	USD	1 Quarter
Royalty revenue	`RoyaltyIncomeNonoperating`	$611.17K	USD	1 Quarter
Royalty revenue	`RoyaltyIncomeNonoperating`	$1.87M	USD	3 Qtrs
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-0.69	USD	1 Quarter
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-0.56	USD	1 Quarter
Royalty revenue	`RoyaltyIncomeNonoperating`	$1.22M	USD	3 Qtrs
Royalty revenue	`RoyaltyIncomeNonoperating`	$414.25K	USD	1 Quarter
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-1.94	USD	3 Qtrs
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-3.64	USD	3 Qtrs
Total revenue	`Revenues`	$1.87M	USD	3 Qtrs
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.52M	shares	3 Qtrs
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.43M	shares	1 Quarter
Total revenue	`Revenues`	$1.22M	USD	3 Qtrs
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.39M	shares	3 Qtrs
Total revenue	`Revenues`	$611.17K	USD	1 Quarter
Total revenue	`Revenues`	$414.25K	USD	1 Quarter
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.53M	shares	1 Quarter
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.43M	shares	1 Quarter
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.53M	shares	1 Quarter
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.39M	shares	3 Qtrs
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.52M	shares	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$398.80K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.58M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.52M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.02M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.61M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$863.23K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.80M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$737.24K	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.26M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$5.13M	USD	3 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$6.37M	USD	3 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$1.76M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-847.79K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.26M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.15M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.15M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-2.58K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-666.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-1.71K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$24.98K	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$87.34K	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$45.48K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$91.80K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$272.00K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$43.77K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$91.13K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$296.98K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$84.76K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-804.02K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.96M	USD	3 Qtrs

Cash Flow Statement 38 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-804.02K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.96M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentsInProcess`	-	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentsInProcess`	$1.30M	USD	3 Qtrs
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	-	USD	3 Qtrs
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$27.04K	USD	3 Qtrs
Share-based expense	`EmployeeBenefitsAndShareBasedCompensation`	$208.51K	USD	3 Qtrs
Share-based expense	`EmployeeBenefitsAndShareBasedCompensation`	$392.83K	USD	3 Qtrs
Prepaid expenses and other	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-133.25K	USD	3 Qtrs
Prepaid expenses and other	`IncreaseDecreaseInAccountsAndOtherReceivables`	$924.47K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$313.92K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-362.50K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-4.66K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-370.25K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.90M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.32M	USD	3 Qtrs
Net cash paid to acquire in-process research and development	`PaymentsToAcquireInProcessResearchAndDevelopment`	-	USD	3 Qtrs
Net cash paid to acquire in-process research and development	`PaymentsToAcquireInProcessResearchAndDevelopment`	$500.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-500.00K	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-3.32M	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-4.40M	USD	3 Qtrs
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.78M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.10M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.85M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.24M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.78M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.10M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.85M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.24M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	-	USD	3 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$2.00	USD	3 Qtrs
Issuance of common stock to acquire in-process research and development	`IssuanceOfCommonStockToAcquireInprocessResearchAndDevelopment`	$805.00K	USD	3 Qtrs
Issuance of common stock to acquire in-process research and development	`IssuanceOfCommonStockToAcquireInprocessResearchAndDevelopment`	-	USD	3 Qtrs

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$18.39M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$15.19M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$11.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$13.65M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$14.52M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$10.89M	USD	Point-in-time
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$208.51K	USD	3 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$392.83K	USD	3 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$137.36K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$70.27K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-804.02K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.96M	USD	3 Qtrs
Issuance of common stock to adjust for reverse split rounding	`StockIssuedDuringPeriodValueReverseStockSplits`	0.00	shares	3 Qtrs
Issuance of common stock in connection with purchase of in-process research and development	`IssuanceOfCommonStockInConnectionWithPurchaseOfInprocessResearchAndDevelopment`	$805.00K	USD	3 Qtrs
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	3 Qtrs
Ending balance, value	`StockholdersEquity`	$18.39M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$15.19M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$11.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$13.65M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$14.52M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$10.89M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.